Jim Kremidas is currently the Executive Director for ACRP, a not-for profit association the represents the clinical research enterprise. Prior to that he conducted consulting services for a variety of clients including support for investigator sites, academic institutions, sponsors and sup-pliers. He was the SVP of Patient Recruitment at two different large CROs for over 6 years where he and his team were responsible for de-veloping and implementing patient enrollment strategies for global clin-ical trials. Prior to that, he spent 24 years with Eli Lilly and Company. From 1999 to 2008 he led their clinical trial patient recruitment and re-tention efforts. In this role, he focused on predicting and accelerating the enrollment rates for all corporate studies. While in Strategic Sourc-ing he was responsible for the outsourcing of clinical development pro-jects to strategic suppliers including CRO’s, scientific staffing firms and Patient Recruitment Suppliers. Before his assignment in clinical devel-opment strategic sourcing, Mr. Kremidas led Lilly’s efforts to select and establish relationships with direct to consumer and professional adver-tising agencies, as well as, implement standardized processes for the de-velopment and implementation of marketing materials.
He is on the advisory board of CISCRP (a non-profit organization fo-cused on enhancing patient participation in clinical trials) and is also a volunteer for the Clinical Trial Transformation Initiative (CTTI) with Duke and the FDA. He is a frequent presenter at Industry Conferences and his articles/papers have been published in a wide variety of trade journals